Oculis Holding AG shares plunged >35% after both Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema failed primary ...
In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD Company to ...
THIRUVANANTHAPURAM: Kerala Chief Minister V D Satheesan’s announcement after the first Cabinet meeting about creating a ...
Prediabetes — the condition’s name more or less says it all. Defined by a blood sugar level that is higher than it should be ...
Newly-released figures show a staggering 110 out of 111 NHS trusts that have specialist ophthalmology units in the UK failed ...
Fatty fish like salmon, cod, sardines, pollack, and anchovies are rich in omega-3 fatty acids. These healthy, unsaturated ...
SussexWorld on MSN
Diabetes Week: Sussex charity raises awareness of the link to sight loss
See the latest news from Your World at https://www.sussexexpress.co.uk/your-world ...
An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic ...
I was in an abusive relationship for 15 years that affected my children badly. I have had emotional problems since I was a ...
Oculis will not pursue FDA approval for OCS-01, an eye drop for diabetic macular edema, after it failed to meet the primary ...
An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic ...
European commercialization introduces an additional aflibercept biosimilar option for major retinal indications, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results